Helen Hobbs, MD, internationally renowned for her work defining the genetic determinants of plasma lipid levels and cardiovascular risk, will kick off the 2019 Flexner Discovery Lecture series Thursday, Jan. 10.

Three Vanderbilt scientists will discuss innovative new and ongoing programs during a Cutting-Edge Discovery Lecture on Thursday, Dec. 13. The lecture will begin at 4 p.m. in room 208 Light Hall.

Lynne Maquat, PhD, recipient of the 2017 Vanderbilt Prize in Biomedical Science, shared some career advice with graduate students and postdoctoral fellows at her Vanderbilt Prize lecture last week.

Stephen B. Baylin, MD, a leading cancer researcher from the Johns Hopkins School of Medicine, described his trailblazing studies of cancer epigenetics last week during a Flexner Discovery Lecture.

Lynne Maquat, PhD, recipient of the 2017 Vanderbilt Prize in Biomedical Science whose work has advanced our understanding of human gene expression, will deliver her Vanderbilt Prize lecture as part of the Flexner Discovery Lecture series on Nov. 29.

Stephen Baylin, MD, a trailblazer in the study of the epigenetics of cancer, will deliver the next Flexner Discovery Lecture on Thursday, Nov. 8. His lecture, sponsored by the Vanderbilt-Ingram Cancer Center, will begin at 4 p.m. in room 208 Light Hall.

Jeffrey Kahn, PhD, MPH, director of the Johns Hopkins Berman Institute of Bioethics, spoke about the role of bioethics in precision medicine during his recent Flexner Discovery Lecture.